Join ACD/Labs part of Revvity Signals at the 25th EuroQSAR Symposium, Leveraging Computation for the Discovery of New Medicines. Bringing together experts in computational drug design, the symposium will explore the latest advances in AI, machine learning, molecular modeling, and in silico approaches to drug discovery.
Visit our poster during the poster sessions to explore a quantitative physicochemical approach to predicting P-glycoprotein inhibition, showcasing how a minimal set of molecular descriptors can be used to model this challenging ADME endpoint.
Poster Presentation
Development of a Quantitative Physicochemical Model for Predicting P-glycoprotein Inhibition
Andrius Sazonovas; Director of Percepta Solutions; ACD/Labs